New Phase III Data For QNASL® Nasal Aerosol Presented At The 2012 ACAAI Meeting

Teva Pharmaceutical Industries Ltd. have announced that additional data from the Phase III clinical program for QNASL® (beclomethasone dipropionate) Nasal Aerosol will be presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, CA on November 8-13, 2012...

Source: http://www.medicalnewstoday.com/releases/252542.php

Grouplove Forever The Sickest Kids Lil Wayne Mac Miller